Patents by Inventor Jean-Philippe Meyer
Jean-Philippe Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170172184Abstract: Methods for recombinant production of vanillin and compositions containing vanillin are provided by this invention.Type: ApplicationFiled: February 12, 2015Publication date: June 22, 2017Inventors: Neil GOLDSMITH, Esben Halkjaer HANSEN, Jean-Philippe MEYER, Federico BRIANZA
-
Patent number: 9260406Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.Type: GrantFiled: March 7, 2013Date of Patent: February 16, 2016Assignee: Evolva SAInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Prathama S. Mainkar, Melya Hughes Crameri
-
Publication number: 20140288110Abstract: 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.Type: ApplicationFiled: March 24, 2014Publication date: September 25, 2014Applicant: EVOLVA SAInventors: Karsten KRISTIANSEN, Prathama S. MAINKAR, Jean-Philippe MEYER, Alexandra Santana SORENSEN
-
Patent number: 8722910Abstract: A novel class of diyne compounds and diyne salts provided herein are effective and potent Ole1 protein inhibitors, useful for treating fungal pathogens. Compounds, fungicides and methods are provided as novel, potent and broad spectrum anti-fungal agents for treatment against a wide variety of fungal pathogens in humans and animals, and in the agricultural setting.Type: GrantFiled: January 6, 2012Date of Patent: May 13, 2014Assignee: Evolva AGInventors: Jean-Philippe Meyer, Philipp Knechtle, Katrine Buch Greve, Alexandre M P Santana Sørenson
-
Patent number: 8710252Abstract: The present invention relates to enantiomeric forms of hepoxilin analogs of Formula I-VIII, pharmaceutical compositions thereof, a method for the separation of said enantiomeric forms of hepoxilin analogs comprising applying said hepoxilin to a chiral phase HPLC column and eluting said hepoxilin with an alkane and alcohol solvent mixture. Said enantiomeric forms of hepoxilin analogs of Formula I-VIII were found to be useful in controlling the biological effects of PPAR mediated transcriptional control for the treatment of diseases such as cancer, thromboxane-mediated diseases and for modulating intracellular calcium concentration.Type: GrantFiled: April 19, 2007Date of Patent: April 29, 2014Inventors: Cecil Pace-Asciak, Alexandra SantAna Sorensen, Jean-Philippe Meyer, Peter Denim
-
Publication number: 20130267561Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.Type: ApplicationFiled: March 7, 2013Publication date: October 10, 2013Applicant: Evolva SaInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Mainkar S. Prathama, Melya Hughes Crameri, Thierry Bonnaud, Joanne Kelleher, David Pearson
-
Patent number: 8536196Abstract: Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.Type: GrantFiled: January 18, 2008Date of Patent: September 17, 2013Assignee: Evolva SAInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Prathama S. Mainkar, Melya Hughes Crameri, Thierry Bonnaud, Joanne Kelleher, David Pearson
-
Publication number: 20130197030Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.Type: ApplicationFiled: March 8, 2013Publication date: August 1, 2013Applicant: Evolva SaInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Mainkar S. Prathama
-
Publication number: 20120196822Abstract: A novel class of diyne compounds and diyne salts provided herein are effective and potent Ole1 protein inhibitors, useful for treating fungal pathogens. Compounds, fungicides and methods are provided as novel, potent and broad spectrum anti-fungal agents for treatment against a wide variety of fungal pathogens in humans and animals, and in the agricultural setting.Type: ApplicationFiled: January 6, 2012Publication date: August 2, 2012Applicant: Evolva AGInventors: Jean-Philippe Meyer, Philipp Knechtle, Katrine Buch Greve, Alexandra M. P. Santana Sørensen
-
Publication number: 20120142766Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.Type: ApplicationFiled: January 18, 2008Publication date: June 7, 2012Applicant: EVOLVA SAInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Mainkar S. Prathama
-
Publication number: 20110178112Abstract: 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.Type: ApplicationFiled: January 18, 2007Publication date: July 21, 2011Applicant: EVOLVA SAInventors: Karsten Kristiansen, Prathama S. Mainkar, Jean-Philippe Meyer, Alexandra Santana Sorensen
-
Publication number: 20100273824Abstract: The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.Type: ApplicationFiled: January 18, 2008Publication date: October 28, 2010Applicant: EVOLVA SAInventors: Alexandra Santana Sorensen, Jean-Philippe Meyer, Peteris Alberts, Mainkar S. Prathama
-
Publication number: 20100210727Abstract: The present invention relates to enantiomeric forms of hepoxilin analogs of Formula I-VIII, pharmaceutical compositions thereof, a method for the separation of said enantiomeric forms of hepoxilin analogs comprising applying said hepoxilin to a chiral phase HPLC column and eluting said hepoxilin with an alkane and alcohol solvent mixture. Said enantiomeric forms of hepoxilin analogs of Formula I-VIII were found to be useful in controlling the biological effects of PPAR mediated transcriptional control for the treatment of diseases such as cancer, thromboxane-mediated diseases and for modulating intracellular calcium concentration.Type: ApplicationFiled: April 19, 2007Publication date: August 19, 2010Applicant: EVOLVA S.A.Inventors: Cecil Pace-Asciak, Alexandra SantAna Sorensen, Jean-Philippe Meyer, Peter Demin
-
Patent number: 6391917Abstract: Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of the present invention are also useful in assays for the determination of calcitonin receptor activity.Type: GrantFiled: April 19, 2001Date of Patent: May 21, 2002Assignee: ZymoGenetics, Inc.Inventors: Charles R. Petrie, Patricia A. McKernan, Emma E. Moore, John M. Ostresh, Jean-Philippe Meyer, Richard A. Houghten, Clemencia Pinilla
-
Patent number: 6359144Abstract: The invention provides a rapid approach for combinatorial synthesis and screening of combinatorial libraries of bicyclic guanidine compounds. The present invention further provides the compounds made by the combinatorial synthesis and individually as well as methods of using the same.Type: GrantFiled: February 3, 1998Date of Patent: March 19, 2002Assignee: Lion Bioscience AGInventors: John M. Ostresh, Jean-Philippe Meyer, Colette T. Dooley, Sylvie E. Blondelle, Christa C. Schoner, Richard A. Houghten
-
Patent number: 6255351Abstract: Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of the present invention are also useful in assays for the determination of calcitonin receptor activity.Type: GrantFiled: September 30, 1999Date of Patent: July 3, 2001Assignee: ZymoGenetics, Inc.Inventors: Charles R. Petrie, Patricia A. McKernan, Emma E. Moore, John M. Ostresh, Jean-Philippe Meyer, Richard A. Houghten, Clemencia Pinilla
-
Patent number: 6221913Abstract: Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of the present invention are also useful in assays for the determination of calcitonin receptor activity.Type: GrantFiled: January 20, 1999Date of Patent: April 24, 2001Assignee: ZymoGenetics, Inc.Inventors: Charles R. Petrie, Patricia A. McKernan, Emma E. Moore, John M. Ostresh, Jean-Philippe Meyer, Richard A. Houghten, Clemencia Pinilla
-
Patent number: 5859190Abstract: The invention provides a rapid approach for combinatorial synthesis and screening of libraries of hydantoin and thiohydantoin compounds. The present invention further provides the compounds made by the combinatorial synthesis.Type: GrantFiled: February 4, 1997Date of Patent: January 12, 1999Assignee: Trega Biosciences, Inc.Inventors: Jean-Philippe Meyer, John M. Ostresh, Richard A. Houghten
-
Patent number: 4964321Abstract: An auxiliary shaft (16) mounted coaxially with a main shaft (5) has at the top an eccentric (17) operatively connected via grooving (20, 21) to a tool-fastening plate (13). At the bottom of the auxiliary shaft is a wheel (19) fixed to the eccentric and provided with a recess (18). The recess can engage a fixed lug cam so that a feed motor can cause both the rotary movement of the ball turner and a tool correction effected by a relative rotary movement between the main shaft and the auxiliary shaft. For the sake of accuracy, the angular displacement is limited to an area in which the displacement of the tool-fastening plate caused by the eccentric is substantially linear with the angular displacement. All rotary motions are measured during the operation by a shaft encoder (9) and communicated to a CNC system.Type: GrantFiled: November 2, 1989Date of Patent: October 23, 1990Assignee: Kummer Freres Sa Fabrique de MachinesInventors: Hans-Jurgen Leiber, Jean-Philippe Meyer, Christian F. Kummer
-
Patent number: 4887500Abstract: An auxiliary shaft (16) mounted coaxially with a main shaft (5) has at the top an eccentric (17) operatively connected via grooving (20, 21) to a tool-fastening plate (13). At the bottom of the auxiliary shaft is a wheel (19) fixed to the eccentric and provided with a recess (18). The recess can engage a fixed lug cam so that a feed motor can cause both the rotary movement of the ball turner and a tool correction effected by a relative rotary movement between the main shaft and the auxiliary shaft. For the sake of accuracy, the angular displacement is limited to an area in which the displacement of the tool-fastening plate caused by the eccentric is substantially linear with the angular displacement. All rotary motions are measured during the operation by a shaft encoder (9) and communicated to a CNC system.Type: GrantFiled: April 15, 1988Date of Patent: December 19, 1989Assignee: Kummer Freres SA Fabrique de MachinesInventors: Hans-Jurgen Leiber, Jean-Philippe Meyer, Christian F. Kummer